Ni X - Search Results

1

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.

Yang J, Zhou Y, Ng SK, Huang KC, Ni X, Choi PW, Hasselblatt K, Muto MG, Welch WR, Berkowitz RS, Ng SW. Yang J, et al. Among authors: ni x. BMC Cancer. 2017 Jun 17;17(1):422. doi: 10.1186/s12885-017-3417-z. BMC Cancer. 2017. PMID: 28623900 Free PMC article.

2

Selenium binding protein 1 in ovarian cancer.

Huang KC, Park DC, Ng SK, Lee JY, Ni X, Ng WC, Bandera CA, Welch WR, Berkowitz RS, Mok SC, Ng SW. Huang KC, et al. Among authors: ni x. Int J Cancer. 2006 May 15;118(10):2433-40. doi: 10.1002/ijc.21671. Int J Cancer. 2006. PMID: 16380993 Free article.

3

Characterisation of human kallikrein 6/protease M expression in ovarian cancer.

Ni X, Zhang W, Huang KC, Wang Y, Ng SK, Mok SC, Berkowitz RS, Ng SW. Ni X, et al. Br J Cancer. 2004 Aug 16;91(4):725-31. doi: 10.1038/sj.bjc.6602041. Br J Cancer. 2004. PMID: 15305183 Free PMC article.

4

Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.

Saxena D, Yiu GK, Ni X, Huang KC, Mantovani R, Jacquemin-Sablon AG, Ng SW. Saxena D, et al. Among authors: ni x. Gene. 2004 Nov 10;342(1):145-55. doi: 10.1016/j.gene.2004.07.033. Gene. 2004. PMID: 15527974

5

Multi-Instance Learning for Vocal Fold Leukoplakia Diagnosis Using White Light and Narrow-Band Imaging: A Multicenter Study.

Tie CW, Li DY, Zhu JQ, Wang ML, Wang JH, Chen BH, Li Y, Zhang S, Liu L, Guo L, Yang L, Yang LQ, Wei J, Jiang F, Zhao ZQ, Wang GQ, Zhang W, Zhang QM, Ni XG. Tie CW, et al. Among authors: ni xg. Laryngoscope. 2024 May 27. doi: 10.1002/lary.31537. Online ahead of print. Laryngoscope. 2024. PMID: 38801129

6

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells.

He W, Zhu H, Zhang S, Shu G, Lei H, Wang M, Yin G, Ni X, Wu Q. He W, et al. Among authors: ni x. Epigenetics. 2024 Dec;19(1):2357518. doi: 10.1080/15592294.2024.2357518. Epub 2024 May 26. Epigenetics. 2024. PMID: 38796857 Free article.

7

Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy.

Wang B, Pan J, Zhang T, Ni X, Wei Y, Li X, Fang B, Hu X, Gan H, Wu J, Wang H, Ye D, Zhu Y. Wang B, et al. Among authors: ni x. BMC Cancer. 2024 May 25;24(1):643. doi: 10.1186/s12885-024-12395-3. BMC Cancer. 2024. PMID: 38796422 Free article. Clinical Trial.

8

Effect of sustained measurable residue disease negativity and post-remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults.

Yu J, Luo Y, Wang L, Wang T, Ye M, Chen J, Ni X, Chen L, Gao L, Yang J. Yu J, et al. Among authors: ni x. Cancer Med. 2024 May;13(10):e7310. doi: 10.1002/cam4.7310. Cancer Med. 2024. PMID: 38785213 Free PMC article.

9

Assessing the reproducibility and validity of a food frequency questionnaire for pregnant women from the Chinese Miao ethnic group.

Ni X, Qiao T, Wang R, Wang F, Liang Y, Wei S. Ni X, et al. Front Nutr. 2024 May 7;11:1322225. doi: 10.3389/fnut.2024.1322225. eCollection 2024. Front Nutr. 2024. PMID: 38774260 Free PMC article.

10

Polyvinylpyrrolidone Assisted One-Pot Synthesis of Size-Tunable Cocktail Nanodrug for Multifunctional Combat of Cancer.

Wang C, Pan J, Chen S, Qiu L, Hu H, Ji L, Wang J, Liu W, Ni X. Wang C, et al. Among authors: ni x. Int J Nanomedicine. 2024 May 17;19:4339-4356. doi: 10.2147/IJN.S459428. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38774026 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,318 results

Search Page